Skip to main content
TipRanks
Go Ultimate75% OFF

Global Pharmatech (GBLP) Ratios

6 Followers

Global Pharmatech Ratios

GBLP's free cash flow for Q1 2026 was $-79.94K. For the 2026 fiscal year, GBLP's free cash flow was increased by $0.00 and operating cash flow was $-79.94K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.440.320.310.03
Quick Ratio0.410.270.270.03
Cash Ratio0.030.030.050.00
Solvency Ratio-0.070.050.332.43
Operating Cash Flow Ratio0.02-0.330.63-1.24
Short-Term Operating Cash Flow Coverage0.190.007.830.00
Net Current Asset Value$ -485.67K$ -411.53K$ -430.02K$ -49.26K
Leverage Ratios
Debt-to-Assets Ratio0.110.000.120.00
Debt-to-Equity Ratio-0.670.00-0.250.00
Debt-to-Capital Ratio-2.010.00-0.340.00
Long-Term Debt-to-Capital Ratio0.000.000.000.00
Financial Leverage Ratio-6.25-2.02-2.18-0.03
Debt Service Coverage Ratio-0.7480.934.14-3236.57
Interest Coverage Ratio-113.24-379.56-188.73-3236.57
Debt to Market Cap0.000.000.000.00
Interest Debt Per Share0.000.000.000.00
Net Debt to EBITDA-0.85-0.710.080.00
Profitability Margins
Gross Profit Margin11.15%66.02%50.18%0.00%
EBIT Margin-21.59%-208.11%-35.66%0.00%
EBITDA Margin-19.27%44.84%354.35%0.00%
Operating Profit Margin-21.81%-210.28%-37.21%0.00%
Pretax Profit Margin-21.78%-208.66%-35.85%0.00%
Net Profit Margin-21.78%-208.66%-35.85%0.00%
Continuous Operations Profit Margin-21.78%-208.66%-35.85%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%
EBT Per EBIT99.87%99.23%96.35%100.03%
Return on Assets (ROA)-9.01%-34.09%-4.91%-8025.07%
Return on Equity (ROE)56.28%69.03%10.69%230.01%
Return on Capital Employed (ROCE)56.36%69.56%11.10%229.94%
Return on Invested Capital (ROIC)169.86%69.56%14.89%229.94%
Return on Tangible Assets-9.01%-34.09%-6.43%-8025.07%
Earnings Yield-0.11%-0.15%-0.04%-0.16%
Efficiency Ratios
Receivables Turnover0.950.470.430.00
Payables Turnover0.640.000.120.00
Inventory Turnover9.900.741.250.00
Fixed Asset Turnover3.700.630.460.00
Asset Turnover0.410.160.140.00
Working Capital Turnover Ratio-0.69-0.16-0.240.00
Cash Conversion Cycle-145.471274.90-1810.790.00
Days of Sales Outstanding385.43779.88852.130.00
Days of Inventory Outstanding36.87495.03292.170.00
Days of Payables Outstanding567.760.002955.090.00
Operating Cycle422.301274.901144.300.00
Cash Flow Ratios
Operating Cash Flow Per Share0.00-0.000.00-0.00
Free Cash Flow Per Share0.000.000.00-0.00
Dividend Paid and CapEx Coverage Ratio1.00-1.001.710.00
Capital Expenditure Coverage Ratio1.00-1.001.710.00
Operating Cash Flow Coverage Ratio0.190.007.830.00
Operating Cash Flow to Sales Ratio0.05-3.006.680.00
Free Cash Flow Yield0.00%0.00%0.29%-0.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-762.50-684.85-2693.31-634.09
Price-to-Sales (P/S) Ratio198.761429.01965.610.00
Price-to-Book (P/B) Ratio-513.53-472.74-287.96-1458.50
Price-to-Free Cash Flow (P/FCF) Ratio0.000.00347.33-1147.09
Price-to-Operating Cash Flow Ratio4145.35-476.00144.52-1147.09
Price-to-Earnings Growth (PEG) Ratio15.25-2.2835.910.00
Enterprise Value Multiple-1032.253186.48272.59-634.28
Enterprise Value61.85M94.83M56.59M71.85M
EV to EBITDA-1032.253186.48272.59-634.28
EV to Sales198.931428.69965.900.00
EV to Free Cash Flow0.000.00347.44-1147.09
EV to Operating Cash Flow4148.75-475.89144.56-1147.09
Tangible Book Value Per Share-0.00-0.00-0.00-0.00
Shareholders’ Equity Per Share-0.00-0.00-0.00-0.00
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00
Revenue Per Share0.000.000.000.00
Net Income Per Share-0.00-0.00-0.00-0.00
Tax Burden1.001.001.001.00
Interest Burden1.011.001.011.00
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue0.330.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.00
Income Quality-0.221.44-18.640.55

Currency in USD